FI20041490A0 - Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi - Google Patents

Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi

Info

Publication number
FI20041490A0
FI20041490A0 FI20041490A FI20041490A FI20041490A0 FI 20041490 A0 FI20041490 A0 FI 20041490A0 FI 20041490 A FI20041490 A FI 20041490A FI 20041490 A FI20041490 A FI 20041490A FI 20041490 A0 FI20041490 A0 FI 20041490A0
Authority
FI
Finland
Prior art keywords
risk
detecting
blood pressure
elevated blood
test package
Prior art date
Application number
FI20041490A
Other languages
English (en)
Swedish (sv)
Inventor
Jukka T Salonen
Juha-Matti Aalto
Ricardo Fuentes
Outi Kontkanen
Mia Pirskanen
Pekka Uimari
Original Assignee
Jurilab Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jurilab Ltd Oy filed Critical Jurilab Ltd Oy
Priority to FI20041490A priority Critical patent/FI20041490A0/fi
Publication of FI20041490A0 publication Critical patent/FI20041490A0/fi
Priority to US11/245,248 priority patent/US20060110751A1/en
Priority to EP05813226A priority patent/EP1824996A2/en
Priority to PCT/FI2005/050429 priority patent/WO2006053955A2/en
Priority to CA002587979A priority patent/CA2587979A1/en
Priority to AU2005305765A priority patent/AU2005305765A1/en
Priority to JP2007542026A priority patent/JP2008521392A/ja
Priority to CNA2005800468951A priority patent/CN101103124A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20041490A 2004-11-19 2004-11-19 Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi FI20041490A0 (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20041490A FI20041490A0 (fi) 2004-11-19 2004-11-19 Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi
US11/245,248 US20060110751A1 (en) 2004-11-19 2005-10-07 Method and kit for detecting a risk of essential arterial hypertension
EP05813226A EP1824996A2 (en) 2004-11-19 2005-11-21 Method and kit for detecting a risk of essential arterial hypertension
PCT/FI2005/050429 WO2006053955A2 (en) 2004-11-19 2005-11-21 Method and kit for detecting a risk of essential arterial hypertension
CA002587979A CA2587979A1 (en) 2004-11-19 2005-11-21 Method and kit for detecting a risk of essential arterial hypertension
AU2005305765A AU2005305765A1 (en) 2004-11-19 2005-11-21 Method and kit for detecting a risk of essential arterial hypertension
JP2007542026A JP2008521392A (ja) 2004-11-19 2005-11-21 本態性動脈性高血圧症を発症する危険度を測定する方法とキット
CNA2005800468951A CN101103124A (zh) 2004-11-19 2005-11-21 用于检测原发性动脉高压风险的方法和试剂盒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20041490A FI20041490A0 (fi) 2004-11-19 2004-11-19 Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi

Publications (1)

Publication Number Publication Date
FI20041490A0 true FI20041490A0 (fi) 2004-11-19

Family

ID=33515246

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20041490A FI20041490A0 (fi) 2004-11-19 2004-11-19 Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi

Country Status (4)

Country Link
US (1) US20060110751A1 (fi)
JP (1) JP2008521392A (fi)
CN (1) CN101103124A (fi)
FI (1) FI20041490A0 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177847A1 (en) * 2004-12-09 2006-08-10 Perlegen Sciences, Inc. Markers for metabolic syndrome obesity and insulin resistance
US20100229249A1 (en) * 2008-02-21 2010-09-09 Nat'l University Corporation Ehime University Identification of group of hypertension-susceptibility genes
US8315957B2 (en) * 2009-09-01 2012-11-20 Microsoft Corporation Predicting phenotypes using a probabilistic predictor
CN101892302B (zh) * 2010-03-18 2012-09-19 首都医科大学附属北京安贞医院 高血压易感基因的rs2336384位点的用途及检测试剂盒
CN101892303B (zh) * 2010-03-26 2012-09-19 首都医科大学附属北京安贞医院 高血压易感基因的rs4846085位点的检测方法及检测试剂盒
CN101886121B (zh) * 2010-03-26 2012-09-19 首都医科大学附属北京安贞医院 高血压易感基因的rs873457位点的检测方法及检测试剂盒
CN104168816A (zh) * 2012-04-11 2014-11-26 奥林巴斯株式会社 内窥镜装置和内窥镜系统
CN105200131B (zh) * 2015-09-23 2018-04-03 博奥生物集团有限公司 基于14个snp位点评估外周动脉疾病患病风险的试剂盒
CN107653323B (zh) * 2016-07-23 2021-05-04 华中农业大学 团头鲂转铁蛋白基因snp分子标记及其应用
CN106192017B (zh) * 2016-07-24 2018-05-11 臻和（北京）科技有限公司 一种用于检测高血压的基因芯片及其试剂盒
CN107341347A (zh) * 2017-06-27 2017-11-10 天方创新（北京）信息技术有限公司 基于评分模型对乳腺癌进行风险评分的方法及装置
KR102039529B1 (ko) * 2019-01-31 2019-11-01 주식회사 에스씨엘헬스케어 대사증후군의 위험인자 예측용 단일염기다형성 및 이의 용도
CN110396539A (zh) * 2019-04-29 2019-11-01 广州海思医疗科技有限公司 用于检测高血压用药相关基因多态性的试剂盒和方法

Also Published As

Publication number Publication date
US20060110751A1 (en) 2006-05-25
CN101103124A (zh) 2008-01-09
JP2008521392A (ja) 2008-06-26

Similar Documents

Publication Publication Date Title
FI20060493A0 (fi) Menetelmä ja laitteisto kiinteistön valvontaa varten
FI20090289A (fi) Laitteisto ja menetelmä jarrun kunnon valvomiseksi
DK1848326T3 (da) System, method and apparatus for measuring blood flow and blood volume
FI20041490A0 (fi) Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi
FI20050706A (fi) Menetelmä ja tuote vianilmaisuun
EP1867276A4 (en) BLOOD PRESSURE METER AND BLOOD PRESSURE MEASUREMENT PROCEDURE
FI20041340A0 (fi) Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi
FI20070180A (fi) Menetelmä ja laite pumpun suojaamiseksi käyttämättä perinteisiä antureita
ITBO20050586A1 (it) Metodo e dispositivo per la realizzazione di un pacchetto per sigarette
DE602005013167D1 (de) Verfahren und Einrichtung zur Erkennung von Reifendruckverlust
FI20050530A0 (fi) Menetelmä ja laitteisto suhteellisen pitoisuuden mittauksen kalibroimiseksi
FI20041229A (fi) Kapasitiivinen anturi ja menetelmä kapasitiivisen anturin valmistamiseksi
FI20051175A0 (fi) Menetelmä ja laitteisto kaasun steriloimiseksi
SE528989C8 (sv) Sätt och anordning för sterilisering av förpackningsämnen
GB0419633D0 (en) Method and apparatus for the measurement of blood pressure
FI20041197A0 (fi) Menetelmä optisen kaasunpitoisuuden mittauksen parantamiseksi
SE0501957L (sv) Anordning för mätning av trycket i en gas och dess användning
FI20055231A (fi) Menetelmä ja mittalaite mitata vesipitoisuutta
FI20021783A0 (fi) Menetelmä kardiovaskulaaristen sairauksien riskin havaitsemiseksi
FI20065627A0 (fi) Laitteisto ja menetelmä aivojen toimintatilan määrittämistä varten
FI20022178A0 (fi) Menetelmä ja testipakkaus diabetesriskin havaitsemiseksi
FI20060403A0 (fi) Menetelmä ja laite rasitusten ilmaisemiseksi
SE0500878L (sv) Mätmetod och anordning för gasmätning i människans hålrum
FI20041230A0 (fi) Kantojärjestelylaite ja -menetelmä
SE0602241L (sv) Anordning för detektering av blodläckage från sår

Legal Events

Date Code Title Description
FD Application lapsed